Access Bio Inc (950130) — Cash Flow-to-Debt Ratio
Access Bio Inc (950130) has a Cash Flow-to-Debt Ratio of -0.14x as of June 2025, meaning its operating cash flow of ₩-9.16 Billion could theoretically repay 0% of its total liabilities (₩67.08 Billion) in one year. See financial agility of Access Bio Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Access Bio Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Access Bio Inc across 13 annual periods. For the full cash flow conversion analysis, see Access Bio Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Access Bio Inc (2012–2024)
Year-by-year debt coverage analysis for Access Bio Inc. Check cash flow quality index of Access Bio Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.22x | ₩13.54 Million | ₩61.70 Million | ▲ +28427.1% |
| 2023 | 0.00x | ₩-80.57 Million | ₩104.00 Billion | ▼ -100.1% |
| 2022 | 1.38x | ₩291.33 Million | ₩210.97 Million | ▲ +31.3% |
| 2021 | 1.05x | ₩137.90 Million | ₩131.10 Million | ▼ -99.8% |
| 2020 | 462.09x | ₩36.72 Billion | ₩79.47 Million | ▲ +4368.9% |
| 2019 | -10.82x | ₩-422.24 Million | ₩39.01 Million | ▲ +90.3% |
| 2018 | -111.49x | ₩-5.73 Billion | ₩51.40 Million | ▲ +5.8% |
| 2017 | -118.30x | ₩-5.45 Billion | ₩46.03 Million | ▼ -244657.5% |
| 2016 | 0.05x | ₩2.11 Million | ₩43.68 Million | ▼ -92.8% |
| 2015 | 0.68x | ₩2.87 Billion | ₩4.24 Billion | ▲ +365.5% |
| 2014 | -0.25x | ₩-2.63 Billion | ₩10.35 Billion | ▼ -244.2% |
| 2013 | 0.18x | ₩1.59 Billion | ₩8.99 Billion | ▼ -29.4% |
| 2012 | 0.25x | ₩1.85 Billion | ₩7.38 Billion | — |